2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid
C25H20ClN7O2 — CID 118696762
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid
2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid (PubChem CID 118696762) has the molecular formula C25H20ClN7O2 and a molecular weight of 485.94 g/mol. Its IUPAC name is 2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid.
Molecular Properties
| Compound Name | 2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid |
|---|---|
| PubChem CID | 118696762 |
| Molecular Formula | C25H20ClN7O2 |
| Molecular Weight | 485.94 g/mol |
| Exact Mass | 485.14 |
| IUPAC Name | 2-[1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-2-pyridinyl]-2-cyclopropylethyl]-3H-benzimidazole-5-carboxylic acid |
| SMILES | O=C(O)c1ccc2nc(C(CC3CC3)c3ccc(-c4cc(Cl)ccc4-n4cnnn4)cn3)[nH]c2c1 |
| InChI | InChI=1S/C25H20ClN7O2/c26-17-5-8-23(33-13-28-31-32-33)18(11-17)16-4-6-20(27-12-16)19(9-14-1-2-14)24-29-21-7-3-15(25(34)35)10-22(21)30-24/h3-8,10-14,19H,1-2,9H2,(H,29,30)(H,34,35) |
| InChIKey | NNJHLHKHIDVNRB-UHFFFAOYSA-N |
| XLogP | 4.88 |
| TPSA | 122.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.94 |
| LogP ≤ 5 | 4.88 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118696762 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.